Compare ASTL & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTL | ANGO |
|---|---|---|
| Founded | 1902 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.0M | 462.0M |
| IPO Year | N/A | 2004 |
| Metric | ASTL | ANGO |
|---|---|---|
| Price | $4.70 | $10.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | ★ 1.5M | 343.2K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | ★ 2.17% | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $3.02 | $8.27 |
| 52 Week High | $7.25 | $13.99 |
| Indicator | ASTL | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 47.38 |
| Support Level | $4.20 | $10.37 |
| Resistance Level | $5.25 | $11.03 |
| Average True Range (ATR) | 0.35 | 0.38 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 47.19 | 22.55 |
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.